KDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

Rating guideline recommendations. Within each recommendation, the strength of recommendation is indicated as Level 1, Level 2, or Not Graded, and the quality of the supporting evidence is shown as A, B, C, or D. *The additional category Not Graded typically was used to provide guidance based on common sense or when the topic does not allow adequate application of evidence. The most common examples include recommendations regarding monitoring intervals, counseling, and referral to other clinical specialists. Ungraded recommendations generally are written as simple declarative statements, but are not meant to be interpreted as being stronger recommendations than Level 1 or 2.

Routine screening after kidney transplant. Complete blood cell count includes white blood cells, hemoglobin, and platelets. Screen for diabetes is by fasting blood glucose level, glucose tolerance test, or hemoglobin A_1c level. Lipid profile includes fasting cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglyceride levels. Screens for BK polyoma virus (BKV) and Epstein-Barr virus (EBV) use plasma nucleic acid testing (NAT); EBV screen is for patients with no antibody to EBV at transplant.